ProVise Management Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $909K | Buy |
12,661
+7
| +0.1% | +$539 | 0.07% | 143 |
|
|
2025
Q4 | $1M | Sell |
12,654
-37
| -0.3% | -$2.92K | 0.07% | 134 |
|
|
2025
Q3 | $957K | Sell |
12,691
-9
| -0.1% | -$617 | 0.07% | 134 |
|
|
2025
Q2 | $876K | Sell |
12,700
-150
| -1% | -$9.84K | 0.07% | 136 |
|
|
2025
Q1 | $871K | Sell |
12,850
-4,824
| -27% | -$289K | 0.07% | 136 |
|
|
2024
Q4 | $793K | Sell |
17,674
-60,997
| -78% | -$3.42M | 0.07% | 142 |
|
|
2024
Q3 | $4.95M | Sell |
78,671
-83,387
| -51% | -$4.86M | 0.39% | 69 |
|
|
2024
Q2 | $9.57M | Buy |
162,058
+8,875
| +6% | +$555K | 0.81% | 34 |
|
|
2024
Q1 | $12.2M | Buy |
153,183
+12,844
| +9% | +$981K | 1.06% | 29 |
|
|
2023
Q4 | $11.1M | Buy |
140,339
+4,964
| +4% | +$353K | 0.94% | 30 |
|
|
2023
Q3 | $9.45M | Buy |
135,375
+6,154
| +5% | +$436K | 0.88% | 33 |
|
|
2023
Q2 | $8.93M | Sell |
129,221
-699
| -0.5% | -$49.7K | 0.81% | 36 |
|
|
2023
Q1 | $9.65M | Sell |
129,920
-22,497
| -15% | -$1.89M | 0.92% | 31 |
|
|
2022
Q4 | $14.2M | Buy |
152,417
+4,104
| +3% | +$396K | 1.44% | 16 |
|
|
2022
Q3 | $14.1M | Sell |
148,313
-639
| -0.4% | -$63.3K | 1.58% | 12 |
|
|
2022
Q2 | $13.8M | Buy |
148,952
+783
| +0.5% | +$76.4K | 1.47% | 14 |
|
|
2022
Q1 | $15M | Buy |
148,169
+2,711
| +2% | +$285K | 1.42% | 12 |
|
|
2021
Q4 | $15M | Buy |
145,458
+447
| +0.3% | +$41.3K | 1.36% | 12 |
|
|
2021
Q3 | $12.3M | Buy |
145,011
+515
| +0.4% | +$43.1K | 1.22% | 14 |
|
|
2021
Q2 | $12.1M | Sell |
144,496
-970
| -0.7% | -$79.4K | 1.23% | 14 |
|
|
2021
Q1 | $10.9M | Buy |
145,466
+4,125
| +3% | +$300K | 1.18% | 14 |
|
|
2020
Q4 | $9.65M | Buy |
141,341
+3,685
| +3% | +$240K | 1.11% | 17 |
|
|
2020
Q3 | $8.04M | Buy |
137,656
+2,755
| +2% | +$171K | 1.08% | 21 |
|
|
2020
Q2 | $8.77M | Buy |
134,901
+1,570
| +1% | +$98.9K | 1.26% | 15 |
|
|
2020
Q1 | $7.91M | Sell |
133,331
-2,388
| -2% | -$159K | 1.33% | 13 |
|
|
2019
Q4 | $10.1M | Buy |
135,719
+1,012
| +0.8% | +$71.1K | 1.24% | 17 |
|
|
2019
Q3 | $8.5M | Buy |
134,707
+10,490
| +8% | +$622K | 1.13% | 20 |
|
|
2019
Q2 | $6.77M | Buy |
124,217
+28,490
| +30% | +$1.53M | 0.91% | 33 |
|
|
2019
Q1 | $5.16M | Buy |
95,727
+11,422
| +14% | +$705K | 0.72% | 40 |
|
|
2018
Q4 | $5.52M | Buy |
84,305
+51,745
| +159% | +$3.86M | 0.87% | 34 |
|
|
2018
Q3 | $2.56M | Sell |
32,560
-252
| -0.8% | -$18K | 0.34% | 89 |
|
|
2018
Q2 | $2.11K | Buy |
32,812
+1,994
| +6% | +$131K | 0.16% | 120 |
|
|
2018
Q1 | $1.92M | Buy |
30,818
+5,297
| +21% | +$380K | 0.28% | 101 |
|
|
2017
Q4 | $1.85M | Buy |
25,521
+821
| +3% | +$59.7K | 0.27% | 100 |
|
|
2017
Q3 | $2.01M | Sell |
24,700
-226
| -0.9% | -$17.9K | 0.29% | 97 |
|
|
2017
Q2 | $2M | Sell |
24,926
-675
| -3% | -$53.3K | 0.3% | 97 |
|
|
2017
Q1 | $2.01M | Sell |
25,601
-300
| -1% | -$23.9K | 0.32% | 93 |
|
|
2016
Q4 | $2.04M | Sell |
25,901
-1,873
| -7% | -$152K | 0.35% | 92 |
|
|
2016
Q3 | $2.47M | Buy |
27,774
+366
| +1% | +$34.5K | 0.43% | 72 |
|
|
2016
Q2 | $2.63M | Sell |
27,408
-2,666
| -9% | -$266K | 0.48% | 64 |
|
|
2016
Q1 | $3.12M | Buy |
30,074
+1,626
| +6% | +$158K | 0.64% | 40 |
|
|
2015
Q4 | $2.78M | Buy |
28,448
+141
| +0.5% | +$13.8K | 0.58% | 48 |
|
|
2015
Q3 | $2.73M | Buy |
28,307
+373
| +1% | +$39.2K | 0.63% | 45 |
|
|
2015
Q2 | $2.93M | Buy |
27,934
+1,000
| +4% | +$102K | 0.62% | 43 |
|
|
2015
Q1 | $2.78M | Sell |
26,934
-200
| -0.7% | -$20.2K | 0.59% | 46 |
|
|
2014
Q4 | $2.61M | Sell |
27,134
-201
| -0.7% | -$17.7K | 0.56% | 48 |
|
|
2014
Q3 | $2.18M | Sell |
27,335
-2,799
| -9% | -$221K | 0.47% | 61 |
|
|
2014
Q2 | $2.27M | Sell |
30,134
-497
| -2% | -$37.6K | 0.49% | 56 |
|
|
2014
Q1 | $2.29M | Buy |
30,631
+600
| +2% | +$42.4K | 0.56% | 50 |
|
|
2013
Q4 | $2.15M | Sell |
30,031
-748
| -2% | -$48.1K | 0.56% | 54 |
|
|
2013
Q3 | $1.75M | Sell |
30,779
-1,153
| -4% | -$68.7K | 0.49% | 57 |
|
|
2013
Q2 | $1.83M | Buy |
+31,932
| New | +$1.85M | 0.54% | 48 |
|
Other funds holding CVS
VCM
VPM
ProVise Management Group's CVS Position: Q1 2026 in Review
ProVise Management Group increased its CVS Health (CVS) stake by 0.06% in Q1 2026, buying an estimated $539 and bringing the position to 12,661 shares worth $909K. The position accounts for 0.07% of the portfolio, ranked #143.
ProVise Management Group first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $15M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- ProVise Management Group held 12,661 shares of CVS Health worth $909K as of Q1 2026.
- ProVise Management Group bought 7 CVS Health shares in Q1 2026, an estimated $539.
- CVS Health made up 0.07% of ProVise Management Group's portfolio in Q1 2026, its #143 holding.
- ProVise Management Group first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- ProVise Management Group's CVS Health position peaked at $15M in Q4 2021.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on ProVise Management Group's 13F filing for Q1 2026, filed 7 May 2026.